Financials
- Market Capitalization 2.46 B
- Employee 361
- Founded 2016
- CEO N/A
- Website www.veratx.com
- Headquarter Delaware, United States
- FIGI BBG00Q72WYG3
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-10.87
市销率
7 992.14
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1857 | PGEN Precigen, Inc. - Common Stock | 6.95 USD | -3.34% | -2.80% | +29.18% | +54.79% | 2.49 B USD | ||
| 1862 | NKTR Nektar Therapeutics - Common Stock | 72.52 USD | -2.72% | -0.67% | +3.57% | -1.02% | 2.48 B USD | ||
| 1880 | TRVI Trevi Therapeutics, Inc. - Common Stock | 16.79 USD | -6.51% | -4.60% | -6.93% | +134.83% | 2.39 B USD | ||
| 1885 | KOD Kodiak Sciences Inc - Common Stock | 37.72 USD | -3.58% | -2.05% | -7.82% | +326.21% | 2.37 B USD |